Back

Commissioning and reimbursement of atrial fibrillation ablation in Europe.

20 June 2017 (14:45 - 15:07)
Organised by:
Congress Presentation Part of: Is it worth the money? Cost-effectiveness in electrophysiology Databases, Registries and Surveys EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Frieder Braunschweig

Karolinska University Hospital, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.
Doctor J. Caldwell (Hull, GB)
Slides Video
Presentation thumbnail
Patient compliance and outcomes of pharmacological therapy and atrial fibrillation ablation.
Professor S. Saksena (Warren, US)
Slides Video
Presentation thumbnail
The role of the ESC Health Policy: relevance to electrophysiology and cardiac device practice.
Professor P. Vardas (Heraklion, GR)
Slides Video

Access the full session

Session thumbnail
Is it worth the money? Cost-effectiveness in electrophysiology

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 14:45 CET
You may be interested in
thumbnail
Congress Presentation
31 August 2019
thumbnail
Congress Presentation
Optimizing persistent atrial fibrillation re-ablation: procedural outcomes of Marshall-plan strategy with a dual-energy lattice-tip catheter ablation
14 April 2026
thumbnail
Congress Presentation
Real-world cost comparison of pulsed field ablation versus radiofrequency ablation with thermal protection in atrial fibrillation
12 April 2026
thumbnail
Congress Presentation
Cutting down time and radiation in atrial fibrillation ablation: lessons from four workflow setups
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources